Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Karrison

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancerWalter M Stadler, Dingcai Cao, Nicholas J Vogelzang, et al.
Journal of Clinical Pharmacology|April 16, 2005
Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humansChun-Su Yuan, Harold Doshan, Martha R Charney, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2011
The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patientsJacqueline Ramírez, Kehua Wu, Linda Janisch, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|December 26, 2007
Reproducibility and sources of variability in radiographic texture analysis of densitometric calcaneal imagesTamara J Vokes, Ann Pham, Joel Wilkie, et al.
Oncotarget|June 11, 2016
WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neckVassiliki Saloura, Theodore Vougiouklakis, Makda Zewde, et al.
Cancer Biology & Therapy|April 26, 2007
A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinomaEdwin M Posadas, Samir Undevia, Elizabeth Manchen, et al.
Cancer|January 12, 2013
A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomasJane E Churpek, Barbara Pro, Koen van Besien, et al.
Cancer Biology & Therapy|June 9, 2006
A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancerAthanassios Argiris, Ezra Cohen, Theodore Karrison, et al.
American Journal of Clinical Pathology|January 11, 2007
Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevantZeba N Singh, Dezheng Huo, John Anastasi, et al.
The Journal of Urology|January 21, 2014
Early removal of urethral catheter with suprapubic tube drainage versus urethral catheter drainage alone after robot-assisted laparoscopic radical prostatectomySandip M Prasad, Michael C Large, Amit R Patel, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancerWalter M Stadler, Dingcai Cao, Nicholas J Vogelzang, et al.
Journal of Clinical Pharmacology|April 16, 2005
Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humansChun-Su Yuan, Harold Doshan, Martha R Charney, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2011
The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patientsJacqueline Ramírez, Kehua Wu, Linda Janisch, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|December 26, 2007
Reproducibility and sources of variability in radiographic texture analysis of densitometric calcaneal imagesTamara J Vokes, Ann Pham, Joel Wilkie, et al.
Oncotarget|June 11, 2016
WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neckVassiliki Saloura, Theodore Vougiouklakis, Makda Zewde, et al.
Cancer Biology & Therapy|April 26, 2007
A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinomaEdwin M Posadas, Samir Undevia, Elizabeth Manchen, et al.
Cancer|January 12, 2013
A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomasJane E Churpek, Barbara Pro, Koen van Besien, et al.
Cancer Biology & Therapy|June 9, 2006
A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancerAthanassios Argiris, Ezra Cohen, Theodore Karrison, et al.
American Journal of Clinical Pathology|January 11, 2007
Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevantZeba N Singh, Dezheng Huo, John Anastasi, et al.
The Journal of Urology|January 21, 2014
Early removal of urethral catheter with suprapubic tube drainage versus urethral catheter drainage alone after robot-assisted laparoscopic radical prostatectomySandip M Prasad, Michael C Large, Amit R Patel, et al.
Pageof 16